Stock Detail
CYTORI THERAPEUTICS INC
Biotechnology
CYTX @ Yahoo Finance | CYTX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.71 | $2.80 | $-0.02 | -0.73% | 0.00 | $2.73 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.72 | $2.70 | 334,488 | 149.96M | 338,715.67 | -3.99 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.84 | 2.78 | 2.74 | 2.68 | 2.64 |
Stock Profile
Cytori Therapeutics, Inc. engages in developing and commercializing stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and serious, chronic, and life threatening conditions. The company develops various products that are in clinical testing stages, which include Celution System, a device that removes stem and regenerative cells from a patient's adipose tissue, as well as used in breast reconstruction applications; Celution PRS System that could be used in plastic and reconstructive surgeries; and Celution CV System for the treatment of chronic myocardial ischemia and heart attacks. Cytori Therapeutics also develops a Celution System, which is under preclinical stage, for investigative applications in gastrointestinal disorders, which could address fistulas and wounds associated with inflammatory disorders, such as Crohn's disease and intestinal repair; peripheral vascular disease; and orthopedic applications, such as bone and spinal disc repair. In addition, it operates a tissue bank facility for the preservation of stem and regenerative cells extracted from adipose tissue. Further, Cytori Therapeutics manufactures macropore biosurgery products that include HYDROSORB family of spine and orthopedic implant products; and thin film bioresorbable soft tissue separation implant products. It has strategic joint venture with Olympus Corporation to develop and manufacture future generation devices based on its Celution system. The company was founded in 1996. It was formerly known as MacroPore, Inc. and changed its name to MacroPore Biosurgery, Inc. Further, the company changed its name to Cytori Therapeutics, Inc. in 2005. Cytori Therapeutics is headquartered in San Diego, California.